MBBP’s Life Sciences Vector Newsletter, Summer 2017

Our Life Sciences team has published the Summer 2017 edition of its Vector newsletter. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. CORPORATE PARTNER MIKE JABBAWY PARTICIPATING ON SHOOBX STARTUP PANEL On September 26, corporate partner Mike Jabbawy will take part in the panel “How …

Continue reading MBBP’s Life Sciences Vector Newsletter, Summer 2017

MBBP’s Life Sciences Vector Newsletter, Spring 2017

Our Life Sciences team has published the Spring 2017 edition of its newsletter, Vector. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information. DAVID CZARNECKI AND STANLEY CHALVIRE ELEVATED WITHIN THE FIRM We are pleased to announce that David Czarnecki and Stanley Chalvire …

Continue reading MBBP’s Life Sciences Vector Newsletter, Spring 2017

MBBP’s Life Sciences Vector, Summer 2016

2016 LIFE SCIENCES PANEL SERIES At the second of our Life Sciences panel Series: “Laying the Foundation for Growth: Entity & Equity”, experts discussed whether a corporation or a limited liability company is the “Right Stuff ” for building an emerging company, and how to structure and optimize the equity compensation of the team. MBBP’s John Hession moderated the panel, which included Marc Cote of …

Continue reading MBBP’s Life Sciences Vector, Summer 2016

MBBP’s Life Sciences Vector, Fall 2015

U.S. INTRODUCTION TO THE HAGUE SYSTEM For many years, non-U.S. parties have taken advantage of the Hague System to register their design patents, an important part of strengthening and differentiating your product and brand. On May 13, 2015, the Hague Agreement Implementation of the Patent Law Treaties Implementation Act of 2012 (PLT) went into effect …

Continue reading MBBP’s Life Sciences Vector, Fall 2015